News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
426,228 Results
Type
Article (30168)
Company Profile (109)
Press Release (395951)
Multimedia
Podcasts (48)
Webinars (9)
Section
Business (109720)
Career Advice (970)
Deals (19692)
Drug Delivery (93)
Drug Development (42142)
Employer Resources (105)
FDA (11589)
Job Trends (10818)
News (190735)
Policy (23517)
Tag
Academia (2180)
Academic (2)
Accelerated approval (3)
Adcomms (16)
Allergies (59)
Alliances (30398)
ALS (53)
Alzheimer's disease (1004)
Antibody-drug conjugate (ADC) (62)
Approvals (11611)
Artificial intelligence (223)
Autoimmune disease (17)
Automation (10)
Bankruptcy (196)
Best Places to Work (9401)
BIOSECURE Act (8)
Biosimilars (89)
Biotechnology (62)
Bladder cancer (55)
Brain cancer (15)
Breast cancer (178)
Cancer (1346)
Cardiovascular disease (139)
Career advice (858)
Career pathing (20)
CAR-T (69)
Cell therapy (233)
Cervical cancer (14)
Clinical research (34813)
Collaboration (559)
Compensation (77)
Complete response letters (13)
COVID-19 (2295)
CRISPR (29)
C-suite (149)
Cystic fibrosis (62)
Data (1460)
Decentralized trials (2)
Denatured (16)
Depression (35)
Diabetes (204)
Diagnostics (5347)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (26)
Drug discovery (81)
Drug pricing (108)
Drug shortages (20)
Duchenne muscular dystrophy (65)
Earnings (37939)
Editorial (31)
Employer branding (9)
Employer resources (93)
Events (75533)
Executive appointments (518)
FDA (12560)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (555)
Gene editing (59)
Generative AI (22)
Gene therapy (187)
GLP-1 (480)
Government (4330)
Grass and pollen (4)
Guidances (56)
Healthcare (15571)
Huntington's disease (13)
IgA nephropathy (19)
Immunology and inflammation (69)
Indications (21)
Infectious disease (2431)
Inflammatory bowel disease (95)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (50)
Interviews (162)
IPO (8428)
IRA (41)
Job creations (1838)
Job search strategy (736)
Kidney cancer (4)
Labor market (16)
Layoffs (308)
Leadership (14)
Legal (5066)
Liver cancer (44)
Lung cancer (195)
Lymphoma (95)
Machine learning (6)
Management (43)
Manufacturing (180)
MASH (50)
Medical device (9780)
Medtech (9783)
Mergers & acquisitions (11633)
Metabolic disorders (514)
Multiple sclerosis (62)
NASH (13)
Neurodegenerative disease (59)
Neuropsychiatric disorders (19)
Neuroscience (1382)
NextGen: Class of 2025 (5149)
Non-profit (4010)
Now hiring (9)
Obesity (278)
Opinion (161)
Ovarian cancer (35)
Pain (57)
Pancreatic cancer (34)
Parkinson's disease (91)
Partnered (16)
Patents (137)
Patient recruitment (73)
Peanut (33)
People (34444)
Pharmaceutical (32)
Pharmacy benefit managers (17)
Phase I (10878)
Phase II (13791)
Phase III (12604)
Pipeline (846)
Policy (126)
Postmarket research (1649)
Preclinical (3478)
Press Release (47)
Prostate cancer (73)
Psychedelics (30)
Radiopharmaceuticals (158)
Rare diseases (276)
Real estate (3113)
Recruiting (43)
Regulatory (15782)
Reports (20)
Research institute (1963)
Resumes & cover letters (97)
Rett syndrome (4)
RNA editing (3)
RSV (39)
Schizophrenia (57)
Series A (88)
Series B (64)
Service/supplier (4)
Sickle cell disease (50)
Special edition (8)
Spinal muscular atrophy (98)
Sponsored (20)
Startups (2180)
Stomach cancer (7)
Supply chain (50)
Tariffs (25)
The Weekly (31)
Vaccines (604)
Venture capitalists (28)
Weight loss (170)
Women's health (33)
Worklife (11)
Date
Today (83)
Last 7 days (547)
Last 30 days (1650)
Last 365 days (22091)
2025 (7451)
2024 (23444)
2023 (26116)
2022 (35880)
2021 (39270)
2020 (39691)
2019 (34900)
2018 (26243)
2017 (19276)
2016 (20100)
2015 (22847)
2014 (17189)
2013 (13717)
2012 (14573)
2011 (14961)
2010 (12954)
Location
Africa (578)
Alabama (44)
Alaska (6)
Arizona (131)
Arkansas (11)
Asia (22939)
Australia (4079)
California (3698)
Canada (1378)
China (327)
Colorado (194)
Connecticut (215)
Delaware (84)
Europe (52942)
Florida (602)
Georgia (165)
Hawaii (1)
Idaho (36)
Illinois (385)
India (23)
Indiana (283)
Iowa (7)
Japan (124)
Kansas (78)
Kentucky (17)
Louisiana (11)
Maine (66)
Maryland (658)
Massachusetts (2863)
Michigan (157)
Minnesota (249)
Mississippi (2)
Missouri (82)
Montana (16)
Nebraska (20)
Nevada (49)
New Hampshire (53)
New Jersey (1304)
New Mexico (12)
New York (1201)
North Carolina (697)
North Dakota (4)
Northern California (1633)
Ohio (140)
Oklahoma (10)
Oregon (24)
Pennsylvania (938)
Puerto Rico (7)
Rhode Island (21)
South America (752)
South Carolina (16)
South Dakota (1)
Southern California (1360)
Tennessee (90)
Texas (499)
United States (15363)
Utah (155)
Virginia (93)
Washington D.C. (46)
Washington State (400)
West Virginia (3)
Wisconsin (51)
426,228 Results for "health decisions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Pharm Country
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA Sciences, Inc. announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC, will utilize the GenXys Health Care Systems suite of clinical decision support software for interpretation and reporting of ADCL’s New York State Department of Health-approved TR8™ pharmacogenomic test.
June 18, 2024
·
5 min read
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Regulatory
5 FDA Decisions to Watch in Q1
Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy for hemophilia A and B.
January 6, 2025
·
8 min read
·
Tristan Manalac
Press Releases
Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development
January 23, 2025
·
5 min read
Podcast
NextGen Class of 2025, M&A Uptick Predicted Heading Into JPM, FDA Decisions to Watch
BioSpace
presents 25 noteworthy biopharma startups in ’25; analysts forecast stronger M&A as the J.P. Morgan Healthcare Conference kicks off next week; GLP-1s continue to expand their reach as Novo, Lilly fight against compounders; and a look ahead to five key FDA decisions in Q1.
January 8, 2025
·
1 min read
·
Heather McKenzie
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Vaccines
After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’
The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its investigational COVID-19 vaccine.
April 24, 2025
·
2 min read
·
Tristan Manalac
Genetown
Axena Health receives two additional positive insurance coverage decisions for Leva
Axena Health, Inc. announced that Highmark Blue Cross Blue Shield and Blue Cross Blue Shield of North Dakota have both added the Leva® Pelvic Health System as a covered benefit for their members suffering with urinary incontinence.
April 11, 2024
·
6 min read
1 of 42,623
Next
